DIANTHUS THERAPEUTICS INC : RAYMOND JAMES RAISES TARGET PRICE TO $131 FROM $125
Raymond James has increased its target price for Dianthus Therapeutics Inc. to $131 from $125. The article, sourced from Reuters, indicates this change in financial outlook for the company. The content primarily highlights this price target adjustment.